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Abstract  Hypertrophic  cardiomyopathy  is  one  of  the  main  causes  of  sudden  cardiac  death  in
young athletes.  Differentiating  between  this  pathological  condition  and  ‘athlete’s  heart’  can  be
quite challenging,  warranting  a  thorough  clinical  and  imaging  assessment.  Clinicians  often  rely
on detraining-induced  attenuation  of  electrocardiographic  and  echocardiographic  findings  as  a
means of  distinguishing  between  pathological  and  physiological  cardiac  remodeling.  This  report
describes  detraining-related  regression  of  left  ventricular  hypertrophy  in  a  young  soccer  player
with a  diagnosis  of  hypertrophic  cardiomyopathy.  It  challenges  the  dogma  that  regression  of
electrocardiographic  abnormalities  and  left  ventricular  hypertrophy  is  exclusive  to  physiological
remodeling  and  questions  the  impact  of  exercise  training  in  the  phenotypic  expression  and
progression  of  hypertrophic  cardiomyopathy.
© 2021  Sociedade  Portuguesa  de  Cardiologia.  Published  by  Elsevier  España,  S.L.U.  This  is  an




Regressão  das  alterações  do  eletrocardiograma  após  pausa  desportiva  --  Nem  sempre
corresponde  a  um  «coração de  atleta» hipertrófica  é  uma  das  principais  causas  de  morte  súbita  de  origem
.  Distinguir  entre  esta  patologia  e  o  ‘‘coração  de  atleta’’  pode  ser
ção  clínica  e  imagiológica  exaustiva.  Frequentemente  recorre-se  à
rocardiográficos  e  ecocardiográficos  induzidos  pela  pausa  desportiva
entre  remodelagem  fisiológica  e  patológica.  Neste  caso  clínicohipertrófica;
Coração  de  atleta;
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descrevemos  a  regressão  da  hipertrofia  ventricular  esquerda  induzida  pela  pausa  desportiva  num
jovem futebolista  com  o  diagnóstico  de  miocardiopatia  hipertrófica.  Este  caso  põe  em  causa
o dogma  de  que  a  regressão  das  alterações  eletrocardiográficas  e  a  da  hipertrofia  ventricular
esquerda  é  exclusiva  da  remodelação  fisiológica  e,  simultaneamente,  levanta  dúvidas  sobre  a
influência do  treino  físico  na  evolução  e  expressão  fenotípica  da  miocardiopatia  hipertrófica.
© 2021  Sociedade  Portuguesa  de  Cardiologia.  Publicado  por  Elsevier  España,  S.L.U.  Este é  um

















































































ypertrophic  cardiomyopathy  (HCM)  is  the  most  common
nherited  cardiovascular  disease.1 It  is  characterized  by  a
ypertrophied  nondilated  left  ventricle  in  the  absence  of
ther  causes.2 HCM  has  a  highly  variable  phenotypic  expres-
ion  and  is  one  of  the  most  common  causes  of  sudden  cardiac
eath  (SCD)  in  young  athletes.3 Differentiating  between  HCM
nd  the  physiological  remodeling  seen  in  ‘athlete’s  heart’
an  be  quite  challenging  and  has  been  the  subject  of  con-
roversy  for  years.4--8 Deconditioning  has  long  been  regarded
s  an  important  tool  to  distinguish  athlete’s  heart  from
ardiomyopathy.  The  idea  that  regression  of  electrocardio-
raphic  (ECG)  and/or  echocardiographic  abnormalities  on
etraining  means  physiological  remodeling  is  widespread
nd  is  in  fact  one  of  the  criteria  proposed  in  the  guidelines
hen  dealing  with  cases  that  fall  into  the  so-called  gray  zone
f  left  ventricular  (LV)  wall  thickness.9
We  present  a  case  report  that  may  challenge  this  dogma:
 22-year-old  male  soccer  player  with  an  apical  form  of  HCM
ho  experienced  significant  regression  of  LV  hypertrophy,
s  expressed  by  ECG  and  echocardiographic  changes,  after
etraining.
ase report
 22-year-old  Caucasian  male  soccer  player  undergoing  a
re-participation  exam  (PPE)  presented  a  very  unsettling
CG  (Figure  1),  highly  suggestive  of  cardiomyopathy.  He
as  asymptomatic,  had  a  normal  physical  exam  and  his
amily  history  was  negative  for  cardiovascular  (CV)  disease
nd  SCD.  He  had  been  playing  amateur  soccer  at  regional
evel  for  ten  years,  training  three  days  a  week  (90  min),
ith  a  weekly  match.  The  transthoracic  echocardiogram
TTE)  revealed  a  nondilated  left  ventricle  with  asymmetri-
al  apical  hypertrophy  (maximum  LV  wall  thickness  16  mm)
Figure  1  and  Video  1)  and  normal  left  ventricular  ejection
raction  and  diastolic  function.  On  cardiac  magnetic  res-
nance  (CMR)  the  maximum  apical  thickness  was  14  mm
nd  the  LV  cavity  had  a  spade-like  appearance  during  dias-
ole.  No  late  gadolinium  enhancement  (LGE)  was  detected
Figure  2).  Holter  monitoring  and  treadmill  exercise  testing
ere  normal  (16  metabolic  equivalents,  no  symptoms  and  no
rrhythmias)  and  genetic  testing  was  negative  for  the  fol-
owing  mutations:  MYH7, MYBPC3,  ACTC1,  TNNT2, TNNI3,






Taken  together,  these  findings  were  compatible  with  an
pical  form  of  HCM  and  he  was  advised  against  participation
n  competitive  sports.
Follow-up  assessment  was  performed  four  months  later.
e  had  reportedly  respected  our  warning  and  barely  exer-
ised  in  the  meantime.  While  still  abnormal,  the  ST-segment
epression  and  deeply  inverted  T  waves  had  become  less
rominent  (Figure  3).  We  repeated  the  TTE  and  had  a  sim-
lar  impression:  although  maximum  wall  thickness  in  the
pex  was  significantly  decreased  (10-11  mm)  and  not  diag-
ostic  of  HCM,  the  TTE  seemed  clearly  abnormal,  given  the
mall  cavity,  the  abnormal  geometry  and  the  apical  gradient
Figures  3  and  4  and  Video  2).
These  ECG  abnormalities  had  already  been  detected  two
ears  before  our  ‘PPE’  and  led  to  a  proposal  for  a  decon-
itioning  period.  We  had  access  to  these  ECGs  and  the
attern  of  pseudo-normalization  was  the  same  as  shown  in
igures  1  and  3.
The  recommendation  not  to  participate  in  competitive
ports  was  reinforced  and  the  young  man  is  asymptomatic
nd  free  of  CV  events  to  date.
iscussion
n  this  case  giant  T-wave  inversions  (TWI)  prompted  sec-
ndary  investigation.  The  prevalence  of  ECG  repolarization
bnormalities  among  athletes  has  been  reported  to  be
-5%.10 TWI  in  the  inferior  and  lateral  leads  have  been  iden-
ified  in  1.5-1.8%  of  adult  Caucasian  athletes,  while  TWI
n  the  lateral  leads  have  been  identified  in  only  0.3%.10
ome  studies  have  shed  light  on  the  long-term  outcome
f  apparently  healthy  athletes  with  marked  repolarization
bnormalities.  Pelliccia  et  al.  identified  81  subjects  (from  a
atabase  of  12  550  trained  athletes)  with  marked  repolar-
zation  abnormalities  and  no  apparent  cardiac  disease  who
nderwent  serial  clinical,  ECG  and  TTE  assessment  for  9±7
ears.  Of  the  81  athletes,  a  diagnosis  of  cardiomyopathy
as  made  in  five  (6%).11 Papadakis  et  al.  followed  1243  ath-
etes  for  69.7±29.6  months,  together  with  52  black  patients
ith  confirmed  HCM.  Most  of  the  patients  with  HCM  (77%)
nd  the  three  athletes  eventually  diagnosed  with  HCM  pre-
ented  deep  TWI  in  the  lateral  leads.12 Recently  a  study
onducted  in  2261  peri-pubertal  athletes  found  136  (6%)  to
ave  TWI.  Of  the  group  of  five  presenting  TWI  in  the  infero-
ateral  leads,  three  (60%)  had  significant  TTE  abnormalities,
ncluding  one  case  of  HCM  and  two  of  LV  hypertrophy.13
ARTICLE IN PRESS+ModelREPC-1787; No. of Pages 6
Revista  Portuguesa  de  Cardiologia  xxx  (xxxx)  xxx--xxx
Figure  1  Resting  electrocardiogram  (ECG)  (top)  and  transthoracic  echocardiogram  (TTE)  (bottom),  before  detraining.  (A)  ECG
with voltage  criteria  for  LV  hypertrophy  and  marked  deep  T-wave  inversion  in  leads  I,  II,  III,  aVF  and  V3-V6,  with  ST-segment
depression; (B)  TTE  (apical  4-chamber  view),  showing  moderate  asymmetric  hypertrophy,  localized  at  the  mid-apical  segments  of
the left  ventricle,  with  maximum  wall  thickness  of  16  mm.  LA:  left  atrium;  LV:  left  ventricle;  RA:  right  atrium;  RV:  right  ventricle.
Figure  2  Cardiac  magnetic  resonance  before  detraining.  (A-C)  Cine  steady  state  free  precession  sequences  (in  diastole)  with
overlapping echocardiographic  findings  --  similar  wall  thicknesses,  particularly  in  the  LV  apical  segments.  Long-axis  horizontal
views enable  visualization  of  the  apex,  with  a  clearly  abnormal  cavity  morphology,  confirming  the  diagnosis  of  apical  hypertrophic
c
m
ardiomyopathy,  mixed  form,  with  an  ‘ace  of  spades’  configuration
yocardial fibrosis.  LA:  left  atrium;  LV:  left  ventricle;  RA:  right  atriu
3
;  (D-F)  delayed  enhancement  sequences  showing  absence  of
m;  RV:  right  ventricle.
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Figure  3  Resting  electrocardiogram  (ECG)  (top)  and  transthoracic  echocardiogram  (TTE)  (bottom),  performed  four  months  after
detraining.  (A)  The  ECG  shows  a  clear  improvement  of  the  T-wave  abnormalities  in  the  inferior  and  lateral  leads,  although  the  ECG
is still  abnormal;  (B)  on  TTE,  a  decrease  in  both  septal  and  apical  LV  wall  thickness  is  evident  (maximum  11  mm).  LA:  left  atrium;
LV: left  ventricle;  RA:  right  atrium;  RV:  right  ventricle.
Figure  4  Transthoracic  echocardiogram  after  detraining.  Note  the  abnormal  shape  of  the  left  ventricular  cavity  (small  cavity
























 myopathic  left  ventricle,  rather  than  adaptive  remodeling  fol
V: right  ventricle.
chnell  et  al.  recently  published  the  results  of  155  ath-
etes  with  TWI  in  whom  an  identifiable  cardiac  disease
as  demonstrated  in  44.5%.14 These  and  other  studies  sup-
ort  the  conclusion  of  an  editorial  by  Wilson  and  Carré  in
hich  they  state  that  the  vast  majority  of  the  evidence
mplicates  TWI  as  part  of  a  disease  process,  with  a  normal
ardiac  phenotype  that  may  later  develop  into  pathology.
ccordingly,  TWI  in  the  inferolateral  leads  are  not  usually
raining-related  and  should  be  considered  pathological  until
roved  otherwise.  Those  athletes  with  TWI  that  are  asymp-
omatic  and  have  normal  cardiac  evaluation  should  undergo







g  training.  LA:  left  atrium;  LV:  left  ventricle;  RA:  right  atrium;
The  current  diagnostic  criteria  for  HCM  in  adult  patients
re  based  on  the  presence  of  LV  end-diastolic  thickness  of
15  mm  in  one  or  more  myocardial  segments.9,15 In  a  recent
eview,1 Sen-Chowdhry  et  al.  pointed  out  that  these  LV
ypertrophy-based  criteria  are  not  adjusted  for  age,  gender
r  body  surface  area,  and  do  not  consider  normal  regional
ariations  in  LV  dimensions.  Moreover,  they  fail  to  iden-
ify  pathology  in  a large  number  of  patients  whose  hearts
re  macroscopically  normal  (with  wall  thickness  and  cavity
ize  within  normal  limits)  but  already  present  widespread
yocardial  disarray  on  histological  analysis.1 Evidence  is
merging  that  some  forms  of  HCM  may  not  be  captured
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idespread  use  of  CMR.  Flett  et  al.  reported  on  22  patients
ho  had  TWI  (alongside  other  features  consistent  with  HCM)
nd  relative  apical  thickening  (apical:basal  wall  thickness
atio>1)  but  not  LV  wall  thickness  >15  mm.  Given  that  nor-
al  LV  wall  thickness  decreases  from  base  to  apex,  they
roposed  that  this  cohort  represented  an  extension  of  the
pical  HCM  phenotype  and  that  relative  but  not  absolute
pical  hypertrophy  should  be  used  for  the  diagnosis  of  api-
al  HCM.16 These  conclusions  are  supported  by  Wu  et  al.
n  a  recent  study,  in  which  they  prospectively  enrolled  60
therwise  healthy  subjects  with  giant  TWI  and  found  that
he  apical  thickness  (measured  on  CMR)  of  subjects  with
iant  TWI  was  significantly  greater  than  that  of  controls
8.10±1.67  mm  vs.  4.14±1.17  mm  in  males).  Additionally,
he  apical  morphology  of  subjects  with  giant  TWI  was  signi-
cantly  different  from  normal  subjects,  raising  the  question
hether  this  cohort  should  be  included  within  the  scope  of
reclinical  apical  HCM.17 It  should  also  be  borne  in  mind
hat  disease  penetrance  in  HCM  is  age-dependent18 and  in
his  particular  case  we  may  not  yet  be  seeing  full-blown  LV
ypertrophy.
In  conferences  all  over  the  world,  authors  have  been
uestioning  the  widely  held  assumption  that  normalization
or  regression)  of  ECG  and/or  echocardiographic  abnormal-
ties  after  detraining  means  that  such  features  may  be
egarded  as  physiological.  Given  that  there  are  no  prospec-
ive  or  retrospective  trials  testing  this  hypothesis,  their
elief  is  based  on  evidence  arising  from  animal  studies  and
rom  a  few  isolated  case  reports.  In  an  animal  model  of  HCM,
azmierczak  et  al.  showed  that  strenuous  exercise  can  trig-
er  hypertrophy  and  pathological  cardiac  remodeling.  While
uch  changes  were  not  seen  in  >6-month-old  sedentary  mice,
xercised  mice  displayed  them  as  early  as  three  months
ld.19 Kebed  et  al.3 published  a  case  report  of  an  18-year-
ld  hockey  player  with  an  abnormal  ECG  and  apical  HCM  with
aximum  wall  thickness  (MWT)  of  24  mm  on  CMR.  He  dis-
ontinued  athletic  training  and  14  months  after  the  initial
iagnosis  CMR  showed  MWT  of  10  mm  at  the  apex.  The  areas
f  LGE  seen  on  the  initial  CMR  were  unchanged  and,  although
till  abnormal,  the  ECG  changes  were  less  prominent.  He  was
enotype  positive.  The  authors  proposed  that  this  patient
ad  both  athletic  adaptation  to  training  and  HCM.  The  for-
er  had  regressed  while  the  latter  was  responsible  for  the
bnormalities  still  observed  after  detraining.3 A  similar  case
as  reported  by  De  Gregorio  et  al.20 A  16-year-old  male
occer  player  with  deep  TWI  in  the  inferolateral  wall  was
iagnosed  with  HCM  after  TTE  showed  LV  hypertrophy  involv-
ng  both  the  septum  (12.4  mm)  and  the  apex  (15.8  mm).
ild  diastolic  dysfunction  was  revealed  on  TTE  and  CMR
onfirmed  LV  hypertrophy  (anterior  septum  13.5  mm,  apical
all  14  mm,  other  segments  12.5-13  mm),  with  no  evidence
f  LGE.  He  was  disqualified  from  competitive  sports  and
ollow-up  was  scheduled.  Six  months  later,  the  ECG  findings
ad  improved  notably  with  deconditioning  and  a  decrease  in
oth  septal  (12.1  mm)  and  apical  (13  mm)  LV  wall  thickness
as  evident  in  the  TTE.  Once  again,  the  athlete  was  discour-
ged  from  intense  physical  training.  However,  two  months
ater,  before  coming  for  a  12-month  check-up,  he  started
laying  recreational  tennis.  As  a  result,  LV  wall  thickness
ad  increased  again  (apical  thickness  of  14.9  mm),  and  lon-
itudinal  deformation,  wall  synchrony  and  ECG  appearance
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These  two  cases  closely  resemble  the  patient  we  present
ere.  We  hypothesize  that  they  belong  to  a  group  of  patients
ith  HCM  in  whom  disease  penetrance  (and  phenotype
xpression)  may  be  triggered  or  accelerated  by  exercise
raining.  Conversely,  detraining  has  the  opposite  effect.  In
his  group  of  patients,  at  any  given  moment,  imaging  and
CG  findings  reflect  the  sum  of  both  physiological  and  patho-
ogical  adaptations.
That  being  said,  how  should  we  interpret  the  detraining
esponse?  It  can  be  summarized  in  two  sentences:  absence
f  response  to  detraining  suggests  pathological  LV  hypertro-
hy;  and  reduction  of  LV  wall  thickness  may  be  observed
n  physiological  hypertrophy  but  also  in  athletes  with  HCM,
nd  does  not  necessarily  mean  athlete’s  heart.  It  is  worth
entioning  that  athletes  advised  not  to  compete  often  do
ot  comply  and  keep  training,  making  the  interpretation  of
ollow-up  exams  very  difficult.
Decision-making  concerning  eligibility  for  competitive
ports  can  be  very  difficult  and  is  the  subject  of  contro-
ersy.  The  risk  of  adverse  cardiac  events  and  SCD  is  believed
o  be  low  in  apical  HCM.  However,  it  is  not  known  to  what
xtent  exercise  can  accelerate  phenotype  progression  or
ven  act  as  a  trigger  of  malignant  arrhythmias.  Accordingly,
he  current  guidelines  advise  against  competitive  sport  par-
icipation  in  HCM  with  phenotypic  abnormalities.21
In  our  opinion  the  case  reported  here  corresponds  to
pical  HCM  with  subclinical  expression  whose  phenotype  is
ggravated  by  exercise  training.  Despite  the  absence  of  fully
xpressed  disease,  after  discussion  of  the  risks,  the  athlete
as  discouraged  from  participating  in  competitive  sports.
onclusion
vidence  that  implicates  deep  inferolateral  TWI  as  part  of
 disease  process  continues  to  emerge.  These  deep  TWI
ay  represent  incomplete  phenotype  expression,  often  pre-
eding  pathological  abnormalities  in  imaging  modalities.  As
uch,  athletes  with  TWI  and  a  normal  cardiac  assessment
hould  undergo  regular  cardiac  monitoring  with  comprehen-
ive  clinical  and  imaging  assessment,  to  screen  for  possible
isease  expression  and  provide  a  definitive  diagnosis  of  HCM.
oreover,  we  believe  that  continued  clinical  and  ECG/TTE
urveillance  is  warranted  in  athletes  with  significant  LV
ypertrophy,  even  when  initial  assessment  and  response  to
etraining  suggest  athlete’s  heart.
An  important  conclusion  that  can  be  drawn  from  our
ase  report  (and  the  others  presented  above)  is  that  we
annot  blindly  trust  in  detraining-induced  attenuation  of
CG  and  TTE  changes  as  a  marker  of  benign  physiological
daptation.  Complete  or  partial  regression  of  these  changes
ay  be  observed  in  physiological  hypertrophy  but  also  in
thletes  with  cardiomyopathy,  reflecting  the  complex  inter-
ction  between  genetic  and  environmental  factors.
The  current  guidelines  are  still  very  restrictive  concern-
ng  eligibility  for  competitive  sports.  New  evidence  and  use
f  shared  decision  models  may  change  the  approach  to  such
ow-risk  cases  in  the  near  future.onflicts of interest
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upplementary  data  associated  with  this  arti-
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